Inactive Instrument

News InspireMD Inc Nyse

Equities

US45779A8615

Summary

Unlock all the news: Be the first to know and act before the market!

InspireMD Announces Full Exercise of Series H Warrant Tranche for Gross Proceeds of $17.9 Million	Jul. 01	AQ
InspireMD Announces Presentation of Positive One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption Clinical Trial of CGuard at LINC 2024	May. 29	AQ
InspireMD Announces Presentation of Positive One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial of CGuard at LINC 2024	May. 28	AQ
Transcript : InspireMD, Inc., Q1 2024 Earnings Call, May 14, 2024	May. 14
Earnings Flash (NSPR) INSPIREMD Posts Q1 Revenue $1.5M, vs. Street Est of $1.9M	May. 14	MT
InspireMD : Reports First Quarter 2024 Financial Results and Provides Business Update	May. 14	PU
InspireMD, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 13	CI
InspireMD to Report First Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, May 14th	May. 07	AQ
InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference	Apr. 03	AQ
InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024	Mar. 26	AQ
Transcript : InspireMD, Inc., Q4 2023 Earnings Call, Mar 06, 2024	Mar. 06
Earnings Flash (NSPR) INSPIREMD Posts Q4 Revenue $1.8M	Mar. 06	MT
InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update	Mar. 06	AQ
InspireMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 05	CI
InspireMD to Report Fourth Quarter and Full-Year 2023 Financial Results and Provide Corporate Business Update on Wednesday, March 6th	Feb. 28	AQ
InspireMD Appoints Principal Investigators for C-GUARDIANS II Clinical Trial of the SwitchGuard™ Neuroprotection System	Feb. 12	AQ
InspireMD Gets CE Mark Recertification From the European Union	Jan. 31	MT
InspireMD Receives CE Mark Recertification Under EU’s New Medical Device Regulation (MDR) Regulatory Framework	Jan. 31	AQ
InspireMD Announces Appointment of Medical Technology Executive Pete Ligotti as Executive Vice President and General Manager of North America	Jan. 03	AQ
InspireMD, Inc. Announces Appointment of Pete Ligotti as Executive Vice President and General Manager of North America	Jan. 03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News InspireMD Inc Nyse

Equities

US45779A8615

Summary

Filters